Abstract:Umbilical cord-derived mesenchymal stromal cells (UCMSCs) have potential applications in regenerative medicine. UCMSCs have been demonstrated to repair tissue damage in many inflammatory and degenerative diseases. We have previously shown that UCMSC exosomes reduce nerve injury-induced pain in rats. In this study, we characterized UCMSC exosomes using RNA sequencing and proteomic analyses and investigated their protective effects on cisplatin-induced hearing loss in mice. Two independent experiments were designed to investigate the protective effects on cisplatin-induced hearing loss in mice: (i) chronic intraperitoneal cisplatin administration (4 mg/kg) once per day for 5 consecutive days and intraperitoneal UCMSC exosome (1.2 μg/μL) injection at the same time point; and (ii) UCMSC exosome (1.2 μg/μL) injection through a round window niche 3 days after chronic cisplatin administration. Our data suggest that UCMSC exosomes exert protective effects in vivo. The post-traumatic administration of UCMSC exosomes significantly improved hearing loss and rescued the loss of cochlear hair cells in mice receiving chronic cisplatin injection. Neuropathological gene panel analyses further revealed the UCMSC exosomes treatment led to beneficial changes in the expression levels of many genes in the cochlear tissues of cisplatin-injected mice. In conclusion, UCMSC exosomes exerted protective effects in treating ototoxicity-induced hearing loss by promoting tissue remodeling and repair.

What problem does this paper attempt to address?

### The Problem the Paper Attempts to Solve This paper aims to investigate whether exosomes derived from umbilical cord mesenchymal stromal cells (UCMSC) can repair cisplatin-induced loss of mouse ear hair cells and auditory damage. #### Main Research Content: 1. **Exosome Characterization**: - Characterize UCMSC exosomes through RNA sequencing and proteomics analysis. 2. **Protective Effect Experimental Design**: - Two independent experiments were designed to explore the protective effect of UCMSC exosomes on cisplatin-induced hearing loss. - Experiment 1: Intraperitoneal injection of cisplatin (4 mg/kg) for 5 consecutive days, along with intraperitoneal injection of UCMSC exosomes (1.2 μg/μL). - Experiment 2: Injection of UCMSC exosomes (1.2 μg/μL) via the round window route 3 days after cisplatin injection. 3. **Experimental Results**: - UCMSC exosomes significantly improved hearing loss in cisplatin-injected mice and rescued the loss of ear hair cells. - After exosome treatment, many gene expression levels in the cochlear tissue of cisplatin-injected mice showed beneficial changes. - Neuropathological gene panel analysis showed that UCMSC exosomes could reverse various biological pathway changes induced by cisplatin, including apoptosis, autophagy, oxidative stress, etc. #### Conclusion: UCMSC exosomes have a protective effect in treating cisplatin-induced hearing loss and may become a potential therapeutic strategy by promoting tissue remodeling and repair.

Umbilical Cord Mesenchymal Stromal Cell-Derived Exosomes Rescue the Loss of Outer Hair Cells and Repair Cochlear Damage in Cisplatin-Injected Mice